Gill MM, Herrera N, Guilaze R, Mussa A, et al. Virologic Outcomes and ARV Switch Profiles 2 Years After National Rollout of Dolutegravir to Children Less Than 15 Years in Southern Mozambique. Pediatr Infect Dis J 2023 Jul 6. doi: 10.1097/INF.0000000000004037.
PMID: 37409808